ABBV monthly performance report
View ABBV's monthly returns, drawdown, and seasonality trends — updated every month.
ABBV monthly report
—
Key takeaways
- AbbVie (ABBV) closed September 2026 at $263.96, up 2.94% for the month and +18.91% over the trailing 12 months.
- Year-to-date, ABBV is +15.52%, outperforming the S&P 500 which has returned +11.70% YTD.
- The stock is trading +15.06% versus its 200-day moving average ($229.41), a bullish technical signal.
- Over the past three years, ABBV has underperformed the S&P 500 by −0.23%, with a relative strength index reading of 99.9.
- Win rate over the trailing 39 months stands at 64.1% — 25 positive months versus 14 negative months.
AbbVie ended September 2026 at $263.96, posting a monthly return of +2.94%. The S&P 500 returned −0.70% over the same window, leaving relative performance at +3.64%.
The current quarter stands at +4.90% (Q3 2026 (QTD)), while medium-term trend remains constructive: price is +15.06% versus the 200-day moving average ($229.41).
Year-to-date, ABBV is +15.52% against SPY +11.70%, a gap of +3.83%. The stock is currently −1.31% below its 52-week high, with maximum 3-year drawdown at −21.46%.
| Period | ABBV | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | −0.02% | −0.12% | +0.10% |
| 1 Week | +2.66% | −0.34% | +3.00% |
| 1 Month | +2.94% | −0.70% | +3.64% |
| 3 Months | +18.65% | +2.80% | +15.85% |
| 6 Months | +20.16% | +13.85% | +6.31% |
| YTD | +15.52% | +11.70% | +3.83% |
| 12 Months | +18.91% | +15.01% | +3.89% |
| 3 Years | +71.47% | +71.69% | −0.23% |
| Rank | Month | Return |
|---|---|---|
| #1 | Jun 2026 | +15.58% |
| #2 | Feb 2025 | +13.67% |
| #3 | Aug 2025 | +11.31% |
| #4 | Jul 2023 | +11.02% |
| #5 | Sep 2025 | +10.05% |
| Rank | Month | Return |
|---|---|---|
| #1 | Apr 2024 | −10.69% |
| #2 | Nov 2024 | −10.27% |
| #3 | Apr 2025 | −6.88% |
| #4 | Mar 2026 | −6.29% |
| #5 | Oct 2025 | −5.83% |
| Quarter | Return |
|---|---|
| Q2 2025 | −11.41% |
| Q3 2025 | +24.74% |
| Q4 2025 | −1.32% |
| Q1 2026 | −4.81% |
| Q2 2026 | +15.70% |
| Q3 2026 (QTD) | +4.90% |
| Year | Return |
|---|---|
| 2023 | −4.11% |
| 2024 | +14.67% |
| 2025 | +28.58% |
| 2026 | +15.52% |
| Metric | Value |
|---|---|
| 52-Week High | $267.47 (2026-07-29) |
| 52-Week Low | $191.00 (2026-04-29) |
| Current Price | $263.96 |
| 200-Day Moving Average | $229.41 |
| Price vs 200DMA | +15.06% |
| 3-Year Maximum Drawdown | −21.46% (2025-04-21) |
| Current Drawdown from 52W High | −1.31% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 99.9 |
| 3-Year Excess Return vs S&P 500 | −0.23% |
| RS Peak | 111.4 (Mar 2025) |
| RS Trough | 78.7 (May 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was ABBV's return for this report period?
ABBV returned +2.94% in the latest monthly window ending 2026-09-18.
Has ABBV outperformed SPY year to date?
YTD ABBV: +15.52% vs SPY: +11.70%.
What is ABBV's 12-month return?
+18.91% over the trailing 12 months.
Is ABBV above or below its 200-day moving average?
Price is +15.06% versus 200DMA ($229.41).
What is the maximum drawdown in the 3-year window?
−21.46% on 2025-04-21.